Immunix® Precision Medicine Platform
Created to turn biological data into real-time clinical insight
Designed to Power Research
Immunix – the precision medicine platform for acute care – combines our proprietary biobank with AI and machine learning to surface biological insights that other platforms simply can’t see. In collaboration with leading research facilities, those insights fuel the rapid development of new diagnostics and targeted therapies.
Patient-First Approach
Destined to Revolutionize Care for Critical Conditions
Our goal is to change outcomes, to deliver successful clinical trials for conditions like sepsis, ARDS, and pneumonia. Because Immunix integrates directly into EMR systems, care teams see biological insights exactly when and where they need it. That real-time access helps clinicians act faster, supports better patient outcomes, and strengthens the metrics hospitals are measured on, from care quality to financial performance.
A Living Map of Immune-Driven Conditions
Integrating Diagnosis with Treatment
With every trial, with every study, our biobank grows – which means the Immunix platform is a constantly evolving map of biological insights, continuously learning to determine how each patient will respond to particular treatment. This map enables us to connect diagnosis directly to treatment, matching each patient’s biology to the intervention most likely to work for them.
Leading the Way to Successful Clinical Trials
Immunix powers the clinical trials advancing precision medicine in acute care, in partnership with leading academic research centers.
Proprietary Biobank and Dataset
NOSIS™ is the biological engine behind Immunix — one of the largest acute illness biobanks in existence, continuously growing with every patient encounter. Explore the Biobank →
Validated by Peer-Reviewed Evidence
Immunix is the foundation for our ongoing product development, validated by a growing body of peer-reviewed evidence.